Quick Answer
MEDICINOVA INC reported Cash And Cash Equivalents At Carrying Value of $30.81 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -23.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2000: $0.00 | Q4 2000: $0.00 | Q2 2010: $25.36 million | Q3 2010: $31.16 million | Q1 2011: $31.38 million | Q2 2011: $11.92 million | Q3 2011: $8.74 million | Q1 2012: $11.01 million | Q2 2012: $7.26 million | Q3 2012: $5.74 million | Q1 2013: $3.03 million | Q2 2013: $12.02 million | Q3 2013: $10.66 million | Q1 2014: $14.78 million | Q2 2014: $13.50 million | Q3 2014: $11.94 million | Q1 2015: $9.07 million | Q2 2015: $8.58 million | Q3 2015: $23.61 million | Q1 2016: $27.62 million | Q2 2016: $26.57 million | Q3 2016: $24.97 million | Q1 2017: $21.64 million | Q2 2017: $22.89 million | Q3 2017: $24.54 million | Q4 2017: $27.99 million | Q1 2018: $62.94 million | Q2 2018: $64.16 million | Q3 2018: $62.44 million | Q1 2019: $63.21 million | Q2 2019: $61.74 million | Q3 2019: $62.87 million | Q1 2020: $61.33 million | Q2 2020: $60.44 million | Q3 2020: $61.66 million | Q1 2021: $76.30 million | Q2 2021: $77.79 million | Q3 2021: $75.03 million | Q1 2022: $67.70 million | Q2 2022: $65.23 million | Q3 2022: $52.51 million | Q1 2023: $55.26 million | Q2 2023: $52.88 million | Q3 2023: $51.51 million | Q1 2024: $47.14 million | Q2 2024: $44.34 million | Q3 2024: $42.28 million | Q1 2025: $36.57 million | Q2 2025: $34.26 million | Q3 2025: $32.56 million.
- Over the full 18 years of available data (2008 to 2025), MEDICINOVA INC's Cash And Cash Equivalents At Carrying Value has grown by 59.6%.
- Historical annual values: Fiscal year 2025: $30.81 million | Fiscal year 2024: $40.36 million | Fiscal year 2023: $51.00 million | Fiscal year 2022: $18.51 million | Fiscal year 2021: $71.43 million | Fiscal year 2020: $60.04 million | Fiscal year 2019: $63.79 million | Fiscal year 2018: $62.31 million | Fiscal year 2017: $27.99 million | Fiscal year 2016: $24.12 million | Fiscal year 2015: $22.08 million | Fiscal year 2014: $11.67 million | Fiscal year 2013: $6.70 million | Fiscal year 2012: $4.01 million | Fiscal year 2011: $15.09 million | Fiscal year 2010: $28.25 million | Fiscal year 2009: $19.24 million | Fiscal year 2008: $19.30 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: